GregoryA.OttersonMD

Oncology • Columbus, OH

Professor, Internal Medicine, Ohio State University College of Medicine

Join to view full profile

Dr. Otterson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Otterson's full profile

Already have an account?

Office
300 W 10th Ave
2nd Floor
Columbus, OH 43210
Phone+1 614-293-6786

Fax+1 614-293-1470
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Rush University Medical CenterResidency, Internal Medicine, 1986 - 1989
Georgetown University School of MedicineClass of 1986

Certifications & Licensure

OH State Medical License 1998 - 2024
MD State Medical License 1989 - 1999
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACP) American College of Physicians, 2002
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Capecitabine in Treating Patients With Malignant Mesothelioma Start of enrollment: 2000 Nov 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Solid Tumors Start of enrollment: 2001 Jan 01
Unknown status
Phase 1
Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2004 Apr 01
Completed
Phase 1
Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer Start of enrollment: 2004 May 01
Completed
Phase 2
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2008 Aug 14
Completed
Phase 2
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations Start of enrollment: 2012 Mar 16
Completed
Phase 2
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
Terminated
Phase 2, Phase 3
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

CLO24-061: Overall Survival (OS) Impact for NSCLC Patients With irAE and Non-irAE Hospital Admissions During First-Line Pembrolizumab Treatment.
Adam Khorasanchi, Songzhu Zhao, Lai Wei, Mingjia Li, Kevin Ho, Hamzah Abu-Sbeih, Evelyn Goodyear, Austin Secor, Peter Shields, Kai He, Jacob Kaufman, Regan Memmott, As...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.
He, K., Terence M Williams, Eric Miller, Meng Welliver, Jeremy Brownstein, Gregory Otterson, Dwight Owen, Karl Haglund, Peter Shields, Erin Bertino, Carolyn Presley, K...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 20
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Riely, G., Smit, E., Ahn, M., Felip, E., Ramalingam, S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M.,...> ;Future Oncology. 2024 Feb 15
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.
Alexander Wong, Maria Riley, Songzhu Zhao, Jessica Zimmer, Matthew Viveiros, Jing Gennie Wang, Vincent Esguerra, Mingjia Li, Gabrielle Lopez, Kari Kendra, David P Carb...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
A cancer disparities curriculum in a hematology/oncology fellowship program.
Marium Husain, Muhammad Salman Faisal, Dionisia Quiroga, Audrey M Sigmund, Gregory Otterson, Alison Walker, Samilia Obeng-Gyasi, Beth Christian> ;BMC Medical Education. 2023 Oct 17
6 citations
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With-Mutant Metastatic Non-Small-Cell Lung Cancer.
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, Enriqueta Felip, Suresh S Ramalingam, Anne Tsao, Melissa Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Micha...> ;Journal of Clinical Oncology. 2023 Jul 20
2 citations
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Andrew C Johns, Mike Yang, Lai Wei, Madison Grogan, Daniel Spakowicz, Sandipkumar H Patel, Mingjia Li, Marium Husain, Kari L Kendra, Gregory A Otterson, Ashley E Rosko...> ;The Oncologist. 2023 Aug 3
A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation.
Nada Shaker, Chiemezie C Amadi, Meng Welliver, Gregory A Otterson, David A Liebner, Konstantin Shilo> ;International Journal of Surgical Pathology. 2023 Dec 1
3 citations
Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non-s...
Liza C Villaruz, George R Blumenschein Jr, Gregory A Otterson, Ticiana A Leal> ;Cancer. 2023 May 1
Correction: Association between pre‑treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis.
Alex Wong, Maria Riley, Songzhu Zhao, Jing Gennie Wang, Vince Esguerra, Mingjia Li, Gabrielle Lopez, Gregory A Otterson, Kari Kendra, Carolyn J Presley, Lai Wei, Dwigh...> ;Cancer Immunology, Immunotherapy. 2023 Jun 1
3 citations
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya, Madison Grogan, Sandip Patel, Karthik Chakravarthy, Abdul Miah, Daniel Spakowicz, Ga...> ;Cancer Immunology, Immunotherapy. 2023 Jul 1
4 citations
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.
Andrew C Johns, Mike Yang, Lai Wei, Madison Grogan, Sandipkumar H Patel, Mingjia Li, Marium Husain, Kari L Kendra, Gregory A Otterson, Jarred T Burkart, Daniel Spakowi...> ;Cancer Immunology, Immunotherapy. 2023 Jul 1
Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case report.
Ankur Sheel, Junu Bae, Ashlee Asada, Gregory A Otterson, Ragavendra R Baliga, Kristin L Koenig> ;Cardio-Oncology. 2023 Jan 18
2 citations
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis.
Alex Wong, Maria Riley, Songzhu Zhao, Jing Gennie Wang, Vince Esguerra, Mingjia Li, Gabrielle Lopez, Gregory A Otterson, Kari Kendra, Carolyn J Presley, Lai Wei, Dwigh...> ;Cancer Immunology, Immunotherapy. 2023 Jun 1
10 citations
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms.
Dwight H Owen, Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou, Carly Pilcher, Sheryl-Ann Suffren, Gwen Christenson, Nancy Curtis, Megan Jukich, Emily...> ;Clinical Cancer Research. 2023 Feb 16
4 citations
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Abdul Miah, Gabriel Tinoco, Songzhu Zhao, Lai Wei, Andrew Johns, Sandip Patel, Mingjia Li, Madison Grogan, Gabrielle Lopez, Marium Husain, Rebecca Hoyd, Khalid Mumtaz,...> ;Journal of Cancer Research and Clinical Oncology. 2023 May 1
9 citations
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
Luis G Paz-Ares, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong-Seok Lee, Justin F Gainor, Gregory A Otterson, Clarisse Audigier-Valette, Neal Ready, Michael Schenker, He...> ;Journal of Thoracic Oncology. 2023 Jan 1
22 citations
Long-Term Efficacy and Safety of Entrectinib inFusion-Positive NSCLC.
Alexander Drilon, Chao-Hua Chiu, Yun Fan, Byoung Chul Cho, Shun Lu, Myung-Ju Ahn, Matthew G Krebs, Stephen V Liu, Thomas John, Gregory A Otterson, Daniel S W Tan, Teja...> ;JTO Clinical and Research Reports. 2022 Jun 1
11 citations
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
Yizhen Guo, Lai Wei, Sandip H Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li, Tyler Haddad, Andrew Johns, Latha P Ganesan, Yiping Yang, Daniel J Spakowicz, Peter G...> ;Clinical Lung Cancer. 2022 Jun 1
128 citations
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
Luis Paz-Ares, Suresh S. Ramalingam, Tudor-Eliade Ciuleanu, Jong Seok Lee, László Urbán, Reyes Bernabe Caro, Keunchil Park, Hiroshi Sakai, Yuichiro Ohe, Makoto Nishio,...> ;Journal of Thoracic Oncology. 2021 Oct 12
9 citations
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler Haddad, Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan, Gabriella Lopez, Abdul Miah, Lai Wei, Gabriel Tinoco, Brian Riesenberg, Zihai Li...> ;Cancer Immunology, Immunotherapy. 2021 Oct 7
20 citations
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shiri...> ;Journal of the National Comprehensive Cancer Network. 2021 Apr 20
39 citations
Advances in epigenetic therapeutics with focus on solid tumors.
Ning Jin, Tiffany L. George, Gregory A. Otterson, Claire F. Verschraegen, Haitao Wen, David P. Carbone, James G. Herman, Erin M. Bertino, Kai He> ;Clinical Epigenetics. 2021 Apr 20
7 citations
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy.
Hui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, Julie W. Reeser, Michele R. Wing, Eric Samorodnitsky, Melanie A. Krook, Amy M. Smith, Thuy Dao, Jharna Miya, Walter...> ;JTO Clinical and Research Reports. 2021 Apr 1
72 citations
Crizotinib in Patients With MET-Amplified NSCLC
D. Ross Camidge, Gregory A. Otterson, Jeffrey W. Clark, Sai-Hong Ignatius Ou, Jared Weiss, Steven Ades, Geoffrey I. Shapiro, Mark A. Socinski, Danielle Murphy, Umberto...> ;Journal of Thoracic Oncology. 2021 Jun 1
Join now to see all

Journal Articles

Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database
Kai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central